Related Experiment Video
Updated: Sep 3, 2025

External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
Ritodrine in external cephalic version: is it effective and safe?
Sin Ae Kim1, Eun-Hwan Cha1, Kyoung-Chul Chun1
1Department of Obstetrics and Gynecology, Inje University Ilsan Paik Hospital, Seoul, Korea.
Objective:
The external cephalic version (ECV) has been shown to lower the likelihood of cesarean section requirements among pregnant women with breech presentations. In the current study, we investigated the effectiveness and safety of ritodrine as a tocolytic for ECV.
Methods:
A total of 407 pregnant women with breech presentations, who had no contraindications for ECV, were enrolled in this study. Multivariable logistic regression analyses were used to assess the impact of ritodrine use on the safety and efficacy of ECV.
Results:
The overall success rate was 67.6%, and ritodrine use was associated with significantly higher odds of successful ECV after adjusting for confounders. Moreover, using ritodrine did not increase the risk of adverse effects, including temporary changes in fetal heart rate, need for elective or emergency cesarean section due to fetal distress during ECV, low Apgar scores, and perinatal mortality.
Conclusion:
Our results suggest that using ritodrine as a tocolytic during ECV may increase the likelihood of ECV success and may not increase adverse perinatal outcomes.
More Related Videos
Related Concept Videos
Drug Delivery: Enteral Route
Skeletal Muscle Relaxants: Therapeutic Uses
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...

